New Delhi: Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the U.S.
drugmaker told Reuters on Monday, even as global supplies tighten.Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots - one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.India's Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company's application was made in early December.